Pharmaceuticals

Global Antifungals Market Overview: Trends Shaping Growth to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Antifungals Industry By The Forecast Year 2029?

The antifungals market has shown significant expansion in recent years. Its valuation is projected to rise from $27.16 billion in 2024 to reach $29.6 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.0%. The expansion observed historically can be attributed to factors like the prevalence of fungal diseases, an aging global population, developments in healthcare infrastructure, and increased awareness and education.

The antifungals market is projected to undergo significant expansion in the foreseeable future. It is set to expand to $41.2 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.6%. This anticipated growth throughout the forecast period stems from factors such as the rise of new fungal strains, the approval of new regulations, escalating global health concerns, increased investment in healthcare, and enhanced patient education and awareness initiatives. Prominent trends expected in this period include intensified research and development, the growth of telemedicine and e-health, progress in developing antifungal medications, and strategic collaborations and partnerships.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp

Which Drivers Are Supporting Growth Of The Antifungals Market?

The expanding occurrence of fungal infections is anticipated to boost the development of the antifungals market in the future. Fungal infections are conditions resulting from fungi entering and multiplying within or on the body. Fungi have the potential to impact diverse areas of the body, such as the skin, nails, lungs, and mucous membranes. The rising incidence of these infections can be attributed to several factors, including a growing population of immunocompromised people, climate shifts fostering better conditions for fungal proliferation, greater use of broad-spectrum antibiotics disturbing natural microbiomes, inadequate hygiene, urban expansion, and the increasing occurrence of chronic illnesses such as diabetes that make individuals more susceptible to fungal infections. Antifungals are vital in managing fungal diseases by impeding the growth and replication of fungi, either by damaging their cell wall or membrane, obstructing key enzymatic pathways, or hindering their capacity to produce essential constituents, thereby lowering the fungal burden, easing symptoms, and stopping the infection from spreading internally. As an illustration, in September 2024, data from the International Society For Infectious Diseases, a US-based non-profit organization, indicated an annual occurrence of 6.5 million invasive fungal infections, linked to roughly 3.8 million mortalities, with 2.5 million (68%; range 35-90%) of these directly caused by such infections. Consequently, the growing occurrence of fungal infections is projected to stimulate the antifungals market.

Which Key Segments Fueling The Antifungals Market?

The antifungals market covered in this report is segmented –

1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines

2) By Route of Administration: Oral, Parenteral, Topical

3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users

Subsegments:

1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin

2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Ketoconazole

3) By Polyenes: Amphotericin B, Nystatin

4) By Allylamines: Terbinafine, Naftifine

What Are The Latest Industry Trends Transforming The Antifungals Market?

Pharmaceutical developers and manufacturers are expanding their various departments, including research and development, marketing, and manufacturing. This growth is facilitated by forming collaborations and strategic partnerships with other companies and research institutes, with the objective of broadening their product portfolios. Consequently, organizations within the anti-infective drugs market ought to explore strategic collaborations to enhance their operational scope and product offerings, which can lead to increased revenues and sustained competitiveness.

Which Leading Companies Dominate The Antifungals Market Share?

Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Which Region Currently Holds The Largest Share Of The Antifungals Market?

North America was the largest region in the drugs for antifungals market in 2024. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Antifungals Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2442&type=smp

Browse Through More Reports Similar to the Global Antifungals Market 2025, By The Business Research Company

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Smart Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

Organ On Chip Market 2025

https://www.thebusinessresearchcompany.com/report/organ-on-chip-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795